Hikma Pharmaceutical | HIK - Nettoeinkommen

Aktienkurs
1,240.00
Täglich Wechseln
31.00 2.56%
Monatlich
-20.97%
Jährlich
-38.37%
Q1 Prognose
1,214.21




Nettoeinkommen Veränderung Datum
Almirall EUR 19.58M 7M 2025-12
argenx SE USD 532.95M 188.69M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Autolus Therapeutics Ltd USD -79.12M 31.2M 2025-09
Bayer EUR -3.76B 2.79B 2025-12
Fresenius EUR 361M 17M 2025-12
Galapagos EUR 782.15M 984.26M 2025-12
Genmab DKK 336M 141M 2025-06
GlaxoSmithKline GBP 636M 1.38B 2025-12
GRIFOLS EUR 98.25M 28.72M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Lonza CHF 307M 22M 2024-12
Merck EUR 319M 583M 2025-12
Orion EUR 260.5M 164.5M 2025-12
Recordati EUR 117.31M 7.15M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
UCB EUR 857M 649M 2024-12